| Non-CR (63) | CR (10) | p value |
---|---|---|---|
Age (years) | 63.4 ± 9.9 | 65.4 ± 11.2 | 0.455 |
Sex | Â | Â | Â |
Male | 39 | 6 | 0.908 |
Female | 24 | 4 | Â |
T stage | Â | Â | Â |
2 | 12 | 1 | 0.901 |
3 | 45 | 8 | Â |
4 | 6 | 1 | Â |
N stage | Â | Â | Â |
0 | 49 | 9 | 0.487 |
1 | 14 | 1 | Â |
Clinical stage | Â | Â | Â |
≤2 | 48 | 9 | 0.327 |
≥3 | 15 | 1 |  |
Histology | Â | Â | Â |
Differentiated | 61 | 9 | 0.313 |
Undifferentiated | 2 | 1 | Â |
Size | Â | Â | Â |
≤40 mm | 29 | 8 | 0.046* |
>40 mm | 34 | 2 | Â |
Circumferential extent | Â | Â | Â |
≤60% | 27 | 8 | 0.029* |
>60% | 36 | 2 | Â |
Distance from anal verge | Â | Â | Â |
>5 cm | 21 | 5 | 0.307 |
≤5 cm | 42 | 5 |  |
Chemo regimen | Â | Â | Â |
UFT+LV | 55 | 6 | 0.148 |
5Fu | 4 | 2 | Â |
S1 | 4 | 2 | Â |
CEA | Â | Â | Â |
>5.0 ng/ml | 35 | 3 | 0.120 |
≤5.0 ng/ml | 27 | 7 |  |